Related references
Note: Only part of the references are listed.Strong Specific Inhibition of UDP-glucuronosyltransferase 2B7 by Atractylenolide I and III
Qian Zhang et al.
PHYTOTHERAPY RESEARCH (2016)
Human UDP-Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol
Liangliang Zhu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Retinoids and rexinoids in cancer prevention: from laboratory to clinic
Ivan P. Uray et al.
SEMINARS IN ONCOLOGY (2016)
Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition
Attarat Pattanawongsa et al.
DRUG METABOLISM AND DISPOSITION (2016)
The neurotoxic effects of vitamin A and retinoids
Marcos Roberto De Oliveira
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2015)
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development
Shingo Oda et al.
DRUG METABOLISM AND PHARMACOKINETICS (2015)
Vitamin A and Retinoids as Mitochondrial Toxicants
Marcos Roberto de Oliveira
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7
Larry House et al.
XENOBIOTICA (2015)
Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms
Xin Gao et al.
XENOBIOTICA (2015)
The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication
Mohamed Ouzzine et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights
Satya Prakash Tripathi et al.
DRUG METABOLISM REVIEWS (2013)
A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders
Zhong-Ze Fang et al.
JOURNAL OF LIPID RESEARCH (2013)
Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Cody J. Peer et al.
CLINICAL CANCER RESEARCH (2012)
Role of UDP-Glucuronosyltransferase Isoforms in 13-cis Retinoic Acid Metabolism in Humans
Sophie E. Rowbotham et al.
DRUG METABOLISM AND DISPOSITION (2010)
Effect of Retinoids on UDP-Glucuronosyltransferase 2B7 mRNA Expression in Caco-2 Cells
Yuan Lu et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7
Michael J. Miley et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Vitamin A and preterm infants: what we know, what we don't know, and what we need to know
H Mactier et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2005)
Database analyses for the prediction of in vivo drug-drug interactions from in vitro data
K Ito et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
P Tsoutsikos et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Vitamin A modulates the effects of thyroid hormone on UDP-glucuronosyltransferase expression and activity in rat liver
V Haberkorn et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Mechanism of indinavir-induced hyperbilirubinemia
SD Zucker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Influence of vitamin A status on the regulation of uridine (5′-)diphosphate-glucuronosyltransferase (UGT) 1A1 and UGT1A6 expression by L-triiodothyronine
V Haberkorn et al.
BRITISH JOURNAL OF NUTRITION (2001)
4-Hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7
VM Samokyszyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
